MT-RNR1 and hearing loss disorder: To prevent aminoglycoside-induced hearing loss, it might be reasonable to perform mutational screening of the MT-RNR1 gene before the initiation of antibiotic therapy, especially in regions where aminoglycosides are frequently used [62, 63].